img

Global Animal Drug Compounding Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Animal Drug Compounding Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Compounding is the mixing of drugs to fit the unique needs of a patient. AHI and AVMA define it as “customized manipulation of an approved drug or drugs by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs of a particular patient.
The global Animal Drug Compounding market size was US$ 818.9 million in 2024 and is forecast to a readjusted size of US$ 1286.2 million by 2034 with a CAGR of 6.2% during the forecast period 2024-2034.
Animal drug shortages are becoming more common and this is unfortunately predicted to worsen in the years ahead, as per official reports published by veterinarians. This shortage encourages the use of widely available compounded drugs to treat a number of animal diseases. A few critical animal drug shortages highlighted by the U.S. FDA are Flunixine Injectable, 35% Perox-Aid, and Epinephrine. To make medical therapy suitable for animal requirements, compounded drugs with the desired active ingredients are unavailable. For e.g., no FDA approved drug for treating megacolon in cats is currently available in the animal drug compounding market. The only safe and effective therapy to treat chronic cat constipation was removed from the U.S. nearly two decades ago. That is why compounding drugs are the only option for veterinarians to treat animals that need pro-kinetic drug therapy.
In terms of sales (consumption) side, this report focuses on the sales of Animal Drug Compounding by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Animal Drug Compounding market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Animal Drug Compounding market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Triangle Compounding Pharmacy
Lorraine's Pharmacy
Medisca
Diamondback Drugs
ESSENTIAL PHARMACY COMPOUNDING VET
By Type
Anti-Infective Agents
Hormones and Substitutes
Anti-Inflammatory Agents
Others
By Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Diagnostic Centers
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Animal Drug Compounding in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Animal Drug Compounding manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Drug Compounding sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Animal Drug Compounding Definition
1.2 Market by Type
1.2.1 Global Animal Drug Compounding Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Anti-Infective Agents
1.2.3 Hormones and Substitutes
1.2.4 Anti-Inflammatory Agents
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Animal Drug Compounding Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Veterinary Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Animal Drug Compounding Sales
2.1 Global Animal Drug Compounding Revenue Estimates and Forecasts 2018-2034
2.2 Global Animal Drug Compounding Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Animal Drug Compounding Revenue by Region
2.3.1 Global Animal Drug Compounding Revenue by Region (2018-2023)
2.3.2 Global Animal Drug Compounding Revenue by Region (2024-2034)
2.4 Global Animal Drug Compounding Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Animal Drug Compounding Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Animal Drug Compounding Sales Quantity by Region
2.6.1 Global Animal Drug Compounding Sales Quantity by Region (2018-2023)
2.6.2 Global Animal Drug Compounding Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Animal Drug Compounding Sales Quantity by Manufacturers
3.1.1 Global Animal Drug Compounding Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Animal Drug Compounding Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Animal Drug Compounding Sales in 2024
3.2 Global Animal Drug Compounding Revenue by Manufacturers
3.2.1 Global Animal Drug Compounding Revenue by Manufacturers (2018-2023)
3.2.2 Global Animal Drug Compounding Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Animal Drug Compounding Revenue in 2024
3.3 Global Animal Drug Compounding Sales Price by Manufacturers
3.4 Global Key Players of Animal Drug Compounding, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Animal Drug Compounding Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Animal Drug Compounding, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Animal Drug Compounding, Product Offered and Application
3.8 Global Key Manufacturers of Animal Drug Compounding, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Animal Drug Compounding Sales Quantity by Type
4.1.1 Global Animal Drug Compounding Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Animal Drug Compounding Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Animal Drug Compounding Sales Quantity Market Share by Type (2018-2034)
4.2 Global Animal Drug Compounding Revenue by Type
4.2.1 Global Animal Drug Compounding Historical Revenue by Type (2018-2023)
4.2.2 Global Animal Drug Compounding Forecasted Revenue by Type (2024-2034)
4.2.3 Global Animal Drug Compounding Revenue Market Share by Type (2018-2034)
4.3 Global Animal Drug Compounding Price by Type
4.3.1 Global Animal Drug Compounding Price by Type (2018-2023)
4.3.2 Global Animal Drug Compounding Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Animal Drug Compounding Sales Quantity by Application
5.1.1 Global Animal Drug Compounding Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Animal Drug Compounding Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Animal Drug Compounding Sales Quantity Market Share by Application (2018-2034)
5.2 Global Animal Drug Compounding Revenue by Application
5.2.1 Global Animal Drug Compounding Historical Revenue by Application (2018-2023)
5.2.2 Global Animal Drug Compounding Forecasted Revenue by Application (2024-2034)
5.2.3 Global Animal Drug Compounding Revenue Market Share by Application (2018-2034)
5.3 Global Animal Drug Compounding Price by Application
5.3.1 Global Animal Drug Compounding Price by Application (2018-2023)
5.3.2 Global Animal Drug Compounding Price Forecast by Application (2024-2034)
6 North America
6.1 North America Animal Drug Compounding Sales by Company
6.1.1 North America Animal Drug Compounding Revenue by Company (2018-2023)
6.1.2 North America Animal Drug Compounding Sales Quantity by Company (2018-2023)
6.2 North America Animal Drug Compounding Market Size by Type
6.2.1 North America Animal Drug Compounding Sales Quantity by Type (2018-2034)
6.2.2 North America Animal Drug Compounding Revenue by Type (2018-2034)
6.3 North America Animal Drug Compounding Market Size by Application
6.3.1 North America Animal Drug Compounding Sales Quantity by Application (2018-2034)
6.3.2 North America Animal Drug Compounding Revenue by Application (2018-2034)
6.4 North America Animal Drug Compounding Market Size by Country
6.4.1 North America Animal Drug Compounding Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Animal Drug Compounding Revenue by Country (2018-2034)
6.4.3 North America Animal Drug Compounding Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Animal Drug Compounding Sales by Company
7.1.1 Europe Animal Drug Compounding Sales Quantity by Company (2018-2023)
7.1.2 Europe Animal Drug Compounding Revenue by Company (2018-2023)
7.2 Europe Animal Drug Compounding Market Size by Type
7.2.1 Europe Animal Drug Compounding Sales Quantity by Type (2018-2034)
7.2.2 Europe Animal Drug Compounding Revenue by Type (2018-2034)
7.3 Europe Animal Drug Compounding Market Size by Application
7.3.1 Europe Animal Drug Compounding Sales Quantity by Application (2018-2034)
7.3.2 Europe Animal Drug Compounding Revenue by Application (2018-2034)
7.4 Europe Animal Drug Compounding Market Size by Country
7.4.1 Europe Animal Drug Compounding Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Animal Drug Compounding Revenue by Country (2018-2034)
7.4.3 Europe Animal Drug Compounding Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Animal Drug Compounding Sales by Company
8.1.1 China Animal Drug Compounding Sales Quantity by Company (2018-2023)
8.1.2 China Animal Drug Compounding Revenue by Company (2018-2023)
8.2 China Animal Drug Compounding Market Size by Type
8.2.1 China Animal Drug Compounding Sales Quantity by Type (2018-2034)
8.2.2 China Animal Drug Compounding Revenue by Type (2018-2034)
8.3 China Animal Drug Compounding Market Size by Application
8.3.1 China Animal Drug Compounding Sales Quantity by Application (2018-2034)
8.3.2 China Animal Drug Compounding Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Animal Drug Compounding Sales by Company
9.1.1 APAC Animal Drug Compounding Sales Quantity by Company (2018-2023)
9.1.2 APAC Animal Drug Compounding Revenue by Company (2018-2023)
9.2 APAC Animal Drug Compounding Market Size by Type
9.2.1 APAC Animal Drug Compounding Sales Quantity by Type (2018-2034)
9.2.2 APAC Animal Drug Compounding Revenue by Type (2018-2034)
9.3 APAC Animal Drug Compounding Market Size by Application
9.3.1 APAC Animal Drug Compounding Sales Quantity by Application (2018-2034)
9.3.2 APAC Animal Drug Compounding Revenue by Application (2018-2034)
9.4 APAC Animal Drug Compounding Market Size by Region
9.4.1 APAC Animal Drug Compounding Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Animal Drug Compounding Revenue by Region (2018-2034)
9.4.3 APAC Animal Drug Compounding Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Animal Drug Compounding Sales by Company
10.1.1 Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Animal Drug Compounding Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Animal Drug Compounding Market Size by Type
10.2.1 Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Animal Drug Compounding Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Animal Drug Compounding Market Size by Application
10.3.1 Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Animal Drug Compounding Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Animal Drug Compounding Market Size by Country
10.4.1 Middle East, Africa and Latin America Animal Drug Compounding Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Animal Drug Compounding Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Triangle Compounding Pharmacy
11.1.1 Triangle Compounding Pharmacy Company Information
11.1.2 Triangle Compounding Pharmacy Overview
11.1.3 Triangle Compounding Pharmacy Animal Drug Compounding Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Triangle Compounding Pharmacy Animal Drug Compounding Products and Services
11.1.5 Triangle Compounding Pharmacy Animal Drug Compounding SWOT Analysis
11.1.6 Triangle Compounding Pharmacy Recent Developments
11.2 Lorraine's Pharmacy
11.2.1 Lorraine's Pharmacy Company Information
11.2.2 Lorraine's Pharmacy Overview
11.2.3 Lorraine's Pharmacy Animal Drug Compounding Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Lorraine's Pharmacy Animal Drug Compounding Products and Services
11.2.5 Lorraine's Pharmacy Animal Drug Compounding SWOT Analysis
11.2.6 Lorraine's Pharmacy Recent Developments
11.3 Medisca
11.3.1 Medisca Company Information
11.3.2 Medisca Overview
11.3.3 Medisca Animal Drug Compounding Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Medisca Animal Drug Compounding Products and Services
11.3.5 Medisca Animal Drug Compounding SWOT Analysis
11.3.6 Medisca Recent Developments
11.4 Diamondback Drugs
11.4.1 Diamondback Drugs Company Information
11.4.2 Diamondback Drugs Overview
11.4.3 Diamondback Drugs Animal Drug Compounding Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Diamondback Drugs Animal Drug Compounding Products and Services
11.4.5 Diamondback Drugs Animal Drug Compounding SWOT Analysis
11.4.6 Diamondback Drugs Recent Developments
11.5 ESSENTIAL PHARMACY COMPOUNDING VET
11.5.1 ESSENTIAL PHARMACY COMPOUNDING VET Company Information
11.5.2 ESSENTIAL PHARMACY COMPOUNDING VET Overview
11.5.3 ESSENTIAL PHARMACY COMPOUNDING VET Animal Drug Compounding Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 ESSENTIAL PHARMACY COMPOUNDING VET Animal Drug Compounding Products and Services
11.5.5 ESSENTIAL PHARMACY COMPOUNDING VET Animal Drug Compounding SWOT Analysis
11.5.6 ESSENTIAL PHARMACY COMPOUNDING VET Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Animal Drug Compounding Value Chain Analysis
12.2 Animal Drug Compounding Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Animal Drug Compounding Production Mode & Process
12.4 Animal Drug Compounding Sales and Marketing
12.4.1 Animal Drug Compounding Sales Channels
12.4.2 Animal Drug Compounding Distributors
12.5 Animal Drug Compounding Customers
13 Market Dynamics
13.1 Animal Drug Compounding Industry Trends
13.2 Animal Drug Compounding Market Drivers
13.3 Animal Drug Compounding Market Challenges
13.4 Animal Drug Compounding Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Animal Drug Compounding Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Anti-Infective Agents
Table 3. Major Manufacturers of Hormones and Substitutes
Table 4. Major Manufacturers of Anti-Inflammatory Agents
Table 5. Major Manufacturers of Others
Table 6. Global Animal Drug Compounding Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Animal Drug Compounding Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Animal Drug Compounding Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Animal Drug Compounding Revenue Market Share by Region (2018-2023)
Table 10. Global Animal Drug Compounding Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Animal Drug Compounding Revenue Market Share by Region (2024-2034)
Table 12. Global Animal Drug Compounding Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 13. Global Animal Drug Compounding Sales by Region (2018-2023) & (K Units)
Table 14. Global Animal Drug Compounding Sales Market Share by Region (2018-2023)
Table 15. Global Animal Drug Compounding Sales by Region (2024-2034) & (K Units)
Table 16. Global Animal Drug Compounding Sales Market Share by Region (2024-2034)
Table 17. Global Animal Drug Compounding Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 18. Global Animal Drug Compounding Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global Animal Drug Compounding Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Animal Drug Compounding Revenue Share by Manufacturers (2018-2023)
Table 21. Global Animal Drug Compounding Price by Manufacturers 2018-2023 (USD/Unit)
Table 22. Global Key Players of Animal Drug Compounding, Industry Ranking, 2021 VS 2024
Table 23. Global Animal Drug Compounding Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Animal Drug Compounding by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Drug Compounding as of 2024)
Table 25. Global Key Manufacturers of Animal Drug Compounding, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Animal Drug Compounding, Product Offered and Application
Table 27. Global Key Manufacturers of Animal Drug Compounding, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Animal Drug Compounding Sales Quantity by Type (2018-2023) & (K Units)
Table 30. Global Animal Drug Compounding Sales Quantity by Type (2024-2034) & (K Units)
Table 31. Global Animal Drug Compounding Sales Quantity Share by Type (2018-2023)
Table 32. Global Animal Drug Compounding Sales Quantity Share by Type (2024-2034)
Table 33. Global Animal Drug Compounding Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Animal Drug Compounding Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Animal Drug Compounding Revenue Share by Type (2018-2023)
Table 36. Global Animal Drug Compounding Revenue Share by Type (2024-2034)
Table 37. Animal Drug Compounding Price by Type (2018-2023) & (USD/Unit)
Table 38. Global Animal Drug Compounding Price Forecast by Type (2024-2034) & (USD/Unit)
Table 39. Global Animal Drug Compounding Sales Quantity by Application (2018-2023) & (K Units)
Table 40. Global Animal Drug Compounding Sales Quantity by Application (2024-2034) & (K Units)
Table 41. Global Animal Drug Compounding Sales Quantity Share by Application (2018-2023)
Table 42. Global Animal Drug Compounding Sales Quantity Share by Application (2024-2034)
Table 43. Global Animal Drug Compounding Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Animal Drug Compounding Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Animal Drug Compounding Revenue Share by Application (2018-2023)
Table 46. Global Animal Drug Compounding Revenue Share by Application (2024-2034)
Table 47. Animal Drug Compounding Price by Application (2018-2023) & (USD/Unit)
Table 48. Global Animal Drug Compounding Price Forecast by Application (2024-2034) & (USD/Unit)
Table 49. North America Animal Drug Compounding Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America Animal Drug Compounding Sales Quantity by Company (2018-2023) & (K Units)
Table 51. North America Animal Drug Compounding Sales Quantity by Type (2018-2023) & (K Units)
Table 52. North America Animal Drug Compounding Sales Quantity by Type (2024-2034) & (K Units)
Table 53. North America Animal Drug Compounding Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America Animal Drug Compounding Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Animal Drug Compounding Sales Quantity by Application (2018-2023) & (K Units)
Table 56. North America Animal Drug Compounding Sales Quantity by Application (2024-2034) & (K Units)
Table 57. North America Animal Drug Compounding Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America Animal Drug Compounding Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Animal Drug Compounding Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America Animal Drug Compounding Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America Animal Drug Compounding Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Animal Drug Compounding Sales Quantity by Country (2018-2023) & (K Units)
Table 63. North America Animal Drug Compounding Sales Quantity by Country (2024-2034) & (K Units)
Table 64. Europe Animal Drug Compounding Sales Quantity by Company (2018-2023) & (K Units)
Table 65. Europe Animal Drug Compounding Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe Animal Drug Compounding Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Europe Animal Drug Compounding Sales Quantity by Type (2024-2034) & (K Units)
Table 68. Europe Animal Drug Compounding Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Animal Drug Compounding Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Animal Drug Compounding Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Animal Drug Compounding Sales Quantity by Application (2024-2034) & (K Units)
Table 72. Europe Animal Drug Compounding Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Animal Drug Compounding Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Animal Drug Compounding Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe Animal Drug Compounding Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Animal Drug Compounding Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Animal Drug Compounding Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Animal Drug Compounding Sales Quantity by Country (2024-2034) & (K Units)
Table 79. China Animal Drug Compounding Sales Quantity by Company (2018-2023) & (K Units)
Table 80. China Animal Drug Compounding Revenue by Company (2018-2023) & (US$ Million)
Table 81. China Animal Drug Compounding Sales Quantity by Type (2018-2023) & (K Units)
Table 82. China Animal Drug Compounding Sales Quantity by Type (2024-2034) & (K Units)
Table 83. China Animal Drug Compounding Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Animal Drug Compounding Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Animal Drug Compounding Sales Quantity by Application (2018-2023) & (K Units)
Table 86. China Animal Drug Compounding Sales Quantity by Application (2024-2034) & (K Units)
Table 87. China Animal Drug Compounding Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Animal Drug Compounding Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Animal Drug Compounding Sales Quantity by Company (2018-2023) & (K Units)
Table 90. APAC Animal Drug Compounding Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC Animal Drug Compounding Sales Quantity by Type (2018-2023) & (K Units)
Table 92. APAC Animal Drug Compounding Sales Quantity by Type (2024-2034) & (K Units)
Table 93. APAC Animal Drug Compounding Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC Animal Drug Compounding Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Animal Drug Compounding Sales Quantity by Application (2018-2023) & (K Units)
Table 96. APAC Animal Drug Compounding Sales Quantity by Application (2024-2034) & (K Units)
Table 97. APAC Animal Drug Compounding Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC Animal Drug Compounding Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Animal Drug Compounding Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC Animal Drug Compounding Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC Animal Drug Compounding Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Animal Drug Compounding Sales Quantity by Region (2018-2023) & (K Units)
Table 103. APAC Animal Drug Compounding Sales Quantity by Region (2024-2034) & (K Units)
Table 104. Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity by Company (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Animal Drug Compounding Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity by Type (2024-2034) & (K Units)
Table 108. Middle East, Africa and Latin America Animal Drug Compounding Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Animal Drug Compounding Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity by Application (2024-2034) & (K Units)
Table 112. Middle East, Africa and Latin America Animal Drug Compounding Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America Animal Drug Compounding Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Animal Drug Compounding Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Animal Drug Compounding Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Animal Drug Compounding Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity by Country (2024-2034) & (K Units)
Table 119. Triangle Compounding Pharmacy Company Information
Table 120. Triangle Compounding Pharmacy Description and Overview
Table 121. Triangle Compounding Pharmacy Animal Drug Compounding Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 122. Triangle Compounding Pharmacy Animal Drug Compounding Product and Services
Table 123. Triangle Compounding Pharmacy Animal Drug Compounding SWOT Analysis
Table 124. Triangle Compounding Pharmacy Recent Developments
Table 125. Lorraine's Pharmacy Company Information
Table 126. Lorraine's Pharmacy Description and Overview
Table 127. Lorraine's Pharmacy Animal Drug Compounding Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 128. Lorraine's Pharmacy Animal Drug Compounding Product and Services
Table 129. Lorraine's Pharmacy Animal Drug Compounding SWOT Analysis
Table 130. Lorraine's Pharmacy Recent Developments
Table 131. Medisca Company Information
Table 132. Medisca Description and Overview
Table 133. Medisca Animal Drug Compounding Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 134. Medisca Animal Drug Compounding Product and Services
Table 135. Medisca Animal Drug Compounding SWOT Analysis
Table 136. Medisca Recent Developments
Table 137. Diamondback Drugs Company Information
Table 138. Diamondback Drugs Description and Overview
Table 139. Diamondback Drugs Animal Drug Compounding Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 140. Diamondback Drugs Animal Drug Compounding Product and Services
Table 141. Diamondback Drugs Animal Drug Compounding SWOT Analysis
Table 142. Diamondback Drugs Recent Developments
Table 143. ESSENTIAL PHARMACY COMPOUNDING VET Company Information
Table 144. ESSENTIAL PHARMACY COMPOUNDING VET Description and Overview
Table 145. ESSENTIAL PHARMACY COMPOUNDING VET Animal Drug Compounding Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 146. ESSENTIAL PHARMACY COMPOUNDING VET Animal Drug Compounding Product and Services
Table 147. ESSENTIAL PHARMACY COMPOUNDING VET Animal Drug Compounding SWOT Analysis
Table 148. ESSENTIAL PHARMACY COMPOUNDING VET Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Animal Drug Compounding Distributors List
Table 152. Animal Drug Compounding Customers List
Table 153. Animal Drug Compounding Market Trends
Table 154. Animal Drug Compounding Market Drivers
Table 155. Animal Drug Compounding Market Challenges
Table 156. Animal Drug Compounding Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Animal Drug Compounding Product Picture
Figure 2. Global Animal Drug Compounding Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Animal Drug Compounding Market Share by Type in 2024 & 2034
Figure 4. Anti-Infective Agents Product Picture
Figure 5. Hormones and Substitutes Product Picture
Figure 6. Anti-Inflammatory Agents Product Picture
Figure 7. Others Product Picture
Figure 8. Global Animal Drug Compounding Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global Animal Drug Compounding Market Share by Application in 2024 & 2034
Figure 10. Veterinary Hospitals
Figure 11. Veterinary Clinics
Figure 12. Veterinary Diagnostic Centers
Figure 13. Animal Drug Compounding Report Years Considered
Figure 14. Global Animal Drug Compounding Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Animal Drug Compounding Revenue 2018-2034 (US$ Million)
Figure 16. Global Animal Drug Compounding Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 17. Global Animal Drug Compounding Sales Quantity 2018-2034 (K Units)
Figure 18. Global Animal Drug Compounding Sales Quantity Market Share by Region (2018-2023)
Figure 19. Global Animal Drug Compounding Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Animal Drug Compounding Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. North America Animal Drug Compounding Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Animal Drug Compounding Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. Europe Animal Drug Compounding Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Animal Drug Compounding Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. China Animal Drug Compounding Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Animal Drug Compounding Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. APAC Animal Drug Compounding Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity YoY (2018-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Animal Drug Compounding Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Animal Drug Compounding Sales Quantity in 2024
Figure 31. The Top 10 and Top 5 Players Market Share by Animal Drug Compounding Revenue in 2024
Figure 32. Animal Drug Compounding Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 33. Global Animal Drug Compounding Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Animal Drug Compounding Revenue Market Share by Type (2018-2034)
Figure 35. Global Animal Drug Compounding Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Animal Drug Compounding Revenue Market Share by Application (2018-2034)
Figure 37. North America Animal Drug Compounding Revenue Market Share by Company in 2024
Figure 38. North America Animal Drug Compounding Sales Quantity Market Share by Company in 2024
Figure 39. North America Animal Drug Compounding Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Animal Drug Compounding Revenue Market Share by Type (2018-2034)
Figure 41. North America Animal Drug Compounding Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Animal Drug Compounding Revenue Market Share by Application (2018-2034)
Figure 43. North America Animal Drug Compounding Revenue Share by Country (2018-2034)
Figure 44. North America Animal Drug Compounding Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Animal Drug Compounding Sales Quantity Market Share by Company in 2024
Figure 48. Europe Animal Drug Compounding Revenue Market Share by Company in 2024
Figure 49. Europe Animal Drug Compounding Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Animal Drug Compounding Revenue Market Share by Type (2018-2034)
Figure 51. Europe Animal Drug Compounding Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Animal Drug Compounding Revenue Market Share by Application (2018-2034)
Figure 53. Europe Animal Drug Compounding Revenue Share by Country (2018-2034)
Figure 54. Europe Animal Drug Compounding Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 56. France Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 60. China Animal Drug Compounding Sales Quantity Market Share by Company in 2024
Figure 61. China Animal Drug Compounding Revenue Market Share by Company in 2024
Figure 62. China Animal Drug Compounding Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Animal Drug Compounding Revenue Market Share by Type (2018-2034)
Figure 64. China Animal Drug Compounding Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Animal Drug Compounding Revenue Market Share by Application (2018-2034)
Figure 66. APAC Animal Drug Compounding Sales Quantity Market Share by Company in 2024
Figure 67. APAC Animal Drug Compounding Revenue Market Share by Company in 2024
Figure 68. APAC Animal Drug Compounding Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Animal Drug Compounding Revenue Market Share by Type (2018-2034)
Figure 70. APAC Animal Drug Compounding Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Animal Drug Compounding Revenue Market Share by Application (2018-2034)
Figure 72. APAC Animal Drug Compounding Revenue Share by Region (2018-2034)
Figure 73. APAC Animal Drug Compounding Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 78. India Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Animal Drug Compounding Revenue Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Animal Drug Compounding Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Animal Drug Compounding Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Animal Drug Compounding Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Animal Drug Compounding Revenue Share by Country (2018-2034)
Figure 87. Brazil Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Animal Drug Compounding Revenue (2018-2034) & (US$ Million)
Figure 92. Animal Drug Compounding Value Chain
Figure 93. Animal Drug Compounding Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed